Paradigm Health completed the acquisition of clinical research business from Flatiron Health.

Paradigm Health, a health technology platform, completed the acquisition of the clinical research business from Flatiron Health, a database platform designed to organize oncology information. Financial terms were not disclosed. "Clinical research must reflect the populations that new therapies are intended to serve. By combining Paradigm Health's AI-powered platform with Flatiron's proven clinical research infrastructure and research network, we are taking a major step towards our goal of accelerating our impact in the U.S. so that more trials can happen where patients actually receive care," Kent Thoelke, Paradigm Health, CEO.